Related Experiment Video
Updated: Jun 27, 2026

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
MerTK Is Regulated by Orphan Nuclear Receptor 4A1 (NR4A1) and NR4A2 in Colon Cancer Cells
Gargi Sivaram1, Srijana Upadhyay2, Sarah Kakwan3
1Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843, USA.
DIM-3,5 compounds, dual NR4A1/NR4A2 ligands, inhibit MerTK expression in colon cancer cells by targeting NR4A/Sp complexes. This reveals a novel therapeutic strategy for cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Orphan nuclear receptors NR4A1 and NR4A2 are overexpressed in solid tumors.
- These receptors promote tumor growth and MerTK expression.
Purpose of the Study:
- Investigate the effect of DIM-3,5 compounds on MerTK expression.
- Elucidate the regulatory mechanism of MerTK in colon cancer cells.
Main Methods:
- Utilized colon cancer cell lines (SW480, HCT116, CT26).
- Administered DIM-3,5 compounds and performed gene knockdown (NR4A1, NR4A2, Sp1, Sp3, Sp4).
- Employed chromatin immunoprecipitation and luciferase reporter assays.
Main Results:
- DIM-3,5 compounds significantly downregulated MerTK protein and RNA expression.
- NR4A1/NR4A2 knockdown decreased MerTK expression.
- MerTK expression is regulated by NR4A/Sp complexes (NR4A1, NR4A2, Sp1, Sp3, Sp4).
Conclusions:
- DIM-3,5 ligands act as novel inhibitors of MerTK expression in cancer cells.
- NR4A1 and NR4A2 participate in MerTK regulation.
- DIM-3,5 compounds represent a potential therapeutic strategy targeting MerTK in cancer.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Master Transcription Regulators
Mitogens and the Cell Cycle
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Abnormal Proliferation

